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ANNEXURE – I
INTRODUCTION
Malignancies  of  childhood  include  a  well-defined  spectrum  of 
hematolymphoid  neoplasms,  organ  specific  (adrenal,  kidney,  liver) 
neoplasms, soft tissues, bone and nervous system (central and peripheral) 
neoplasms with variable biology. Small round cell tumors (SRCT) are a 
subset  of  childhood  malignancies  that  comprise  a  group  of  diverse, 
diagnostically challenging primitive or undifferentiated neoplasms. These 
tumors have a similar histological appearance that is small round blue 
cells. They share many morphological similarities, however their unique 
biological,  immunohistochemical,  ultrastructural  and  genetic 
characteristics have provided substantial  insights  into the pathology of 
these  diverse  neoplasms.  Traditionally  clinical  features  and  light 
microscopy  with  aid  of  histochemistry  and  ultrastructural  evaluation, 
establish  a  diagnosis.  Additionally,  immunohistology,  cytogenitics  and 
molecular  studies have become important  in diagnosis and in defining 
phenotype  /  genotype,  patient  treatment  modalities  and  prognosis  in 
specific cases.
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AIMS AND OBJECTIVES
1. To  study  the  incidence  of  small  round  cell  tumors  in  pediatric 
population.
2. To study the clinical and histopathological features of small round 
cell tumors.
3. To  confirm  the  histopathological  diagnosis  with  immunohisto-
chemistry wherever it is possible.
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REVIEW OF LITERATURE
Definition of SRCTS of childhood
Denny in his commentary defines the characteristics of small round 
cell tumors (SRCT)1.
SRCTs can be defined in terms of clinical and pathological features 
i.e.  the  routine  histological,  immunohistochemical  and  ultrastructural 
features  and  by  genetic  markers.  Although  microarray  analyses  can 
discriminate between types of SRCTs, a competent pathologist can do it 
with  equal  accuracy  by  using  routine  histological  and  ancillary 
morphologic techniques.
SRCTs  constituting  about  20%  of  the  solid  tumors  in  children 
include the following2.
Small round cell tumors –Table 1
BASIC CONVENTIONAL SPECTRUM
1. Neuroblastoma (NB)
2. Ewings Sarcoma/Peripheral primitive Neuroectodermal Tumors 
(ES/PNET)
3. Rhabdomyosarcoma (RMS)
4. Non Hodgkins lymphoma (NHL)
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EXTENDED SPECTURUM
1. Desmoplastic SRCT (DSRCT)
2. Small cell undifferentiated Osteosarcoma (UOS)
3. Small cell Hepatoblastoma (HBI)
4. Blastemal Wilms Tumor (BWT)
5. Small  cell  variant  of  malignant  peripheral  Nerve  sheath  tumor 
(MPNST)
6. Small cell variant of synovial sarcoma (SS)
7. Unclassifiable SRCT
Precise diagnosis of the tumor type is necessary for selection of 
appropriate  treatment  protocol.  The  clinical  features,  primary  site, 
metastatic  pattern and routine  pathologic  features  provide clues to  the 
diagnosis  whereas  other  features  which include  immunohistochemical, 
ultrastuctural  and  genetic  features  provide  definitive  criteria  for 
diagnosis. The main emphasis is on the various parameters for the basic 
conventional  spectrum  in  children  (Table  1).  The  features  that  prove 
helpful in the diagnosis of the entities in the extended spectrum of SRCTs 
in children with be described briefly.
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EPIDEMIOLOGY OF CHILDHOOD CANCERS
The incidence of childhood cancer in most populations in the world 
ranges  from 75  to  150  per  million  children  per  year. 3,4 However,  the 
reported age of the standardized incidence rate for India ranges from 38 
to 124 per million children per year.The highest  incidence is  reported 
from  Chennai  and  the  lowest  from  rural  Ahmedabad.  The  estimated 
DALYs  the  world  paediatric  population  is  given  in  the  table-2.  The 
incidence of tumours is given in the Figure-1. 
TABLE - 2
Estimated DALYs ('000), by cause and WHO Member State, persons 
aged 0-14 years, 2004
 India         World
Malignant neoplasms 595 3,202
Mouth and oropharynx 
cancers 9 47
Oesophagus cancer 0 6
Stomach cancer 1 15
Colon and rectum cancers 2 13
Liver cancer 12 90
Pancreas cancer 0 3
Trachea, bronchus, lung 
cancers 3 21
Melanoma and other skin 
cancers 1 9
Breast cancer 0 4
Cervix uteri cancer 0 2
Corpus uteri cancer 0 4
Ovary cancer 7 32
Prostate cancer 0 3
Bladder cancer 1 6
Lymphomas, multiple 
myeloma 85 615
Leukaemia 271 1,226
12
Other neoplasms 56 317
Figure - 1
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VARIATION BY SEX
Overall cancer in childhood is more common among males than 
females and the male to female ratio in the most resource-rich countries is 
around  1.2:1. 5,6 However,  some  cancers  like  retinoblastoma,  Wilms' 
tumor, osteosarcoma, and germ cell tumor actually show a slight female 
preponderance.
VARIATION BY CANCER TYPE
Leukemia  is  the  most  common  childhood  cancer  in  India  with 
relative proportion varying between 25 and 40%. Sixty  to  85% of  all 
leukemias  reported  are  acute  lymphoblastic  leukemia  (ALL).  
In  the  developed  world,  CNS  tumors  are  the  second  most  common 
childhood cancer (22-25%) and lymphomas a distant third (10%). 5,6 In 
contrast, in India lymphomas often exceed CNS tumors, particularly in 
males. Not only is the proportion of lymphomas higher in India, but HD 
exceeds non-Hodgkin's lymphoma (NHL), a pattern opposite to that seen 
in the developed world. This specifically seems to be a result of the high 
incidence of HD in male children in India (incidence rate of 8.2-19.6 per 
million children,  per  year,  in Bangalore,  Chennai,  Delhi,  and Mumbai 
PBCRs compared to 5.7 in USA and 6.4 in Britain). 5,6 In contrast,  the 
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incidence of HD in females and of NHL in both sexes is not very different 
from  the  incidence  in  the  developed  world.  Besides  differences  in 
incidence,  the  pathobiology  of  these  cancers  is  also  different.  Among 
NHL, the proportion of T-cell lymphoblastic lymphoma and diffuse large 
B-cell  lymphoma is  much higher  and the proportion of  mature  B-cell 
(Burkitt's and Burkitt-like) lymphoma much lower in India than that seen 
in the developed world. 7 Similar to T-cell ALL, the higher proportion of 
T-cell  NHL  may  be  linked  to  lower  socioeconomic  status.  Mixed 
cellularity  is  the  most  common  Hodgkin's  disease  subtype  and  is 
responsible for  the incidence peak at  a younger age,  as seen in India, 
compared to the peak seen at ages 16 to 30 years in the developed world, 
where nodular sclerosis is most common. 4 The high proportion of mixed 
cellularity in India is thought to be related to early childhood Ebstein Barr 
virus exposure. 8 
Neuroblastoma, which is the second most common solid tumor in 
childhood after CNS tumors,, is much less frequently reported in India. 
Retinoblastoma has an incidence rate of three to five per million children, 
per year, and accounts for 2.5 to 4% of all  childhood cancers in most 
developed countries. Barshi, Chennai, and Delhi report a 2-3 fold higher 
incidence of tumors of the eye (majority of which will be retinoblastoma 
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in children <15 years of  age),  a finding that  has also been previously 
reported. 9,10  Variation  is  also  seen  in  the  incidence  of  tumors  of  the 
kidney (majority of which are Wilms' tumor in children <15 years age), 
with the incidence in Bangalore and Mumbai being half of that seen in 
Delhi, Chennai, and other developed countries.11 Incidence and relative 
proportion of specific types of cancer in childhood in Chennai is given in 
the Table – 3.
TABLE - 3
Number (#) and relative proportion (%) of specific types of cancer in 
childhood Age (0-14 years) (2001-03) – Location Chennai 12
Specific Types of Cancer in Childhood # %
I LEUKAEMIAS 280 42.2
(a) Lymphoid Leukaemia 193 29.1
(b) Acute non-lymphocytic leukaemia 57 8.6
(c) Chronic myeloid leukaemia 11 1.7
(d) Other specified leukaemias 1 0.2
(e) Unsp. Leukaemias 18 2.7
II LYMPHOMAS & RETICULOENDOTHELIAL 
NEOP. 109 16.4
(a) Hodgkin's disease 58 8.7
(b) Non-Hodgkin lymphoma 43 6.5
(c) Burkitt's lymphoma 8 1.2
(d) Misc lymphoreticular neop. 0 0.0
(e) Unsp. Lymphomas 0 0.0
III C.N.S. & MISC. INTRACRANIAL & 
INTRASPINAL NEOP. 30 4.5
(a) Ependymoma 3 0.5
(b) Astrocytoma 11 1.7
(c) Primitive neuroectodermal tumors 6 0.9
(d) Other gliomas 7 1.1
(e) Other specified intracranial and intraspinal neop. 0 0.0
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(f) Unsp. intracranial and intraspinal neop. 3 0.5
IV SYMPATHETIC NERVOUS SYSTEM 
TUMOURS 16 2.4
(a) Neuroblastoma and Ganglioneuroblastoma 15 2.3
(b) Other SNS tumors 1 0.2
V RETINOBLASTOMA 43 6.5
VI RENAL TUMOURS 23 3.5
(a) Wilms's tumor,rhabdoid and clear cell sarcoma 22 3.3
(b) Renal carcinoma 1 0.2
(c) Unsp. malignant renal tumors 0 0.0
VII HEPATIC TUMOURS 4 0.6
(a) Hepatoblastoma 3 0.5
(b) Hepatic carcinoma 1 0.2
(c) Unsp. malignant hepatic tumours 0 0.0
VIII MALIGNANT BONE TUMOURS 65 9.8
(a) Osteosarcoma 40 6.0
(b) Chondrosarcoma 0 0.0
(c) Ewing's sarcoma 22 3.3
(d) Other specified malignant bone tumours 1 0.2
(e) Unsp. malignant bone tumours 2 0.3
IX SOFT-TISSUE(S-T) SARCOMAS(S) 40 6.0
(a) Rhabdomyosarcoma and embryonal sarcoma 22 3.3
(b) Fibros.neurofibros. and other fibromatous neop. 1 0.2
(c) Kaposi's sarcoma 0 0.0
(d) Other specified soft tissue sarcomas 4 0.6
(e) Unsp. soft tissue sarcomas 13 2.0
X GERM-CELL TROPHOBLASTIC & OTH. 
GONADAL NEOP. 18 2.7
(a) Intracranial and intraspinal gc tumours 0 0.0
(b) Other and unsp. non-gonadal gc tumours 0 0.0
(c) Gonadal gc tumours 0 0.0
(d) Gonadal carcinomas 4 0.6
(e) Other and unsp. gonadal tumours 14 2.1
XI CARCINOMA & OTH MALIGNANT 
EPITHELIAL NEOP. 24 3.6
(b) Adrenocortical carcinoma 4 0.6
(a) Thyroid carcinoma 1 0.2
(c) Nasopharyngeal carcinoma 10 1.5
(d) Malignant melanoma 0 0.0
(e) Skin carcinoma 6 0.9
(f) Other and unsp. Carcinomas 3 0.5
XII OTHER & UNSP. MALIGNANT 12 1.8
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NEOPLASMS
(a) Other specified malignant tumours 0 0.0
(b) Other unsp. malignant tumours 12 1.8
XIII. OTHERS (Not Classified) 0 0.0
All Types 664 100.0
INCIDENCE OF SRCT
SRCTs  constitute  around  20%  of  all  the  solid  tumors  in  the 
children2.
Lymphomas are the third common malignancies of children after 
acute leukemias and brain tumors3. Neuroblastoma is the most common 
extra cranial solid tumor in children. It occurs at a rate of about 1 per 
10000 live births14. It accounts for 10-20% of all malignant tumors.
Ewing’s  sarcoma/PNET  constitute  around  6-10%  of  primary 
malignant  bone  tumors.  Extra  skeletal  Ewings  constitute  the  second 
common pediatric soft tissue sarcoma6. Rhabdomyosarcoma is the most 
common pediatric  soft  tissue  sarcoma comprising  80-90% of  reported 
cases17.
Age adjusted incidences of selected cancers per 100000 individuals 
aged 0-19 years are as follows:13
All Sites – 15.9
Leukemias – 3.8
Brain and other nervous tissues – 2.8
Hodgkin disease – 1.3
Non-Hodgkin lymphoma – 1.1
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Bone and joint – 1
Soft tissue – 1
Kidney and renal pelvis – 0.7
AGE AND SEX
Non-Hodgkin lymphoma18 is less common than that of Hodgkins 
lymphoma  in  children.  However  NHL and  acute  leukemias  are  best 
considered  in  terms  of  a  spectrum  ranging  from  clinically  localised 
disease to overt leukemia. Neuroblastomas15 are generally diagnosed in 
early childhood. 50% are below 2 years and 90% of cases below 5 years. 
There is a slight male predilection.
Ewings sarcoma/PNET15 have average age presentation of 10-15 
years. 80% are less than 20 years. Boys are affected more frequently than 
girls  at  a  ratio  of  1.3:1.  Rhahdomyosarcoma19 in  children  occurs 
principally before the age of 10 years with a peak before the age of 4 
years and shows moderate male predominance.
PRIMARY SITE AND METASTATIC PATTERNS
The  most  characteristic  sites  for  the  SRCTs  in  the  basic 
conventional spectrum are as follows.2
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a) Adrenal - Neuroblastoma
b) Bone - ES/PNET
c) Lymph nodes - Non Hodgkins Lymphoma (NHL)
d) Soft tissues - RMS
However exceptions occur like Neuroblastoma of kidney, NHL of 
bone. In rare cases of Neuroblastoma and RMS the primary site may be 
occult.
The characteristic metastatic patterns are as follows.
a) Bone marrow, lymph node liver, orbit and bone – Neuroblastoma
b) Lung and lymph node – ES/PNET & RMS
c) Generalized disease – NHL
However exceptions do occur. Lung and Bone marrow may be the 
site  of  metastases  of  Neuroblastoma  and  intracranial  SRCT  such  as 
central PNET including medulloblastoma may metastasize extra cranially 
to lungs, liver and kidneys. Knowledge of typical metastatic patterns of 
various SRCTs can provide a clue. However, the primary tumors at these 
sites and unusual metastatic patterns will also have to be considered. (e.g. 
Hepatoblastoma  in  liver,  NHL  or  metastatic  undiffentiated 
nasopharyngeal carcinoma in cervical lymphnodes, small cell melanoma 
21
or small cell sweat gland carcinoma or metastatic NB in the biopsy of a 
skin nodule.)
SIGNS AND SYMPTOMS
In general patients with NHL18 appear mildly to moderately ill with 
low-grade fever, pallor, respiratory distress, pain and discomfort. Usually 
present  with  generalized  lymphadenopathy  or  with  abdominal  mass. 
Uncommonly  may  present  with  nasopharyngeal  mass,  or  parotid 
enlargement, nephromegaly or testicular enlargement.
Neuroblastoma18 mostly presents as an abdominal mass in which 
radiologic  imaging  studies  demonstrate  a  suprarenal  or  retroperitoneal 
mass with or without calcifications. Dehner et al enumerates some of the 
uncommon and unusual clinical manifestations of Neuroblastoma:
1. Congenital Neuroblastoma
2. Cutaneous metastasis
3. Fetal hydrops with placental metastases
4. Neuroblastoma “ Leukemia”
5. Opsoclonus – myoclonus with: dancing eyes”
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6. Systemic Hypertension
7. Intractable watery diarrhea (VIP secretion)
8. Heterochromia of iris (Horner syndrome)
9. Cushing syndrome
10.Familial Neuroblastoma
11.Late recurrence and death
Ewings  sarcoma7 typically  presents  as  a  painful  enlarging  mass 
with  features  mimicking  infection  like  fever,  elevated  erythrocyte 
sedimentation rate, anemia and leukocytosis. Plain X-ray study reveals a 
destructive lytic lesion, eroding the cortex producing “saucerisation” of 
the bone and the displaced periosteum deposits layers of reactive bone in 
an onion- skin like fashion.
Rhabomyosarcomas8 usually  manifests  as  an  expanding  mass. 
Typical  presentations  by  the  location  of  non-metastatic  disease  are  as 
follows:
Orbit - Proptosis or dysconjugate gaze
Paratesticular - Painless scrotal mass
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Prostate - Bladder or bowel difficulties
Uterus, Cervix, Vagina - Menorrohagia or metrorrhagea
Bladder                            - Protruding polypoid mass 
(Botryoid   meaning a grapelike 
cluster)
Extremity - Painless mass
Parameningeal (ear,         -       Upper respiratory symptoms or pain
Nasal cavity, paranasal
Sinuses, infratemporal fossa,
 Pterygopalatine  fossa) 
GROSS FEATURES
Neuroblastomas  are  lobulated  masses  averaging  6-8cm  in 
diameter6.  They  often  have  a  delicate  membranous  capsules  that  are 
easily ruptured to yield the soft, fleshy, gray partially hemorrhagic tumor.
Ewings  sarcoma/PNET7 arises  in  the  medullary  cavity  usually 
transgresses the cortex and periosteum producing a soft tissue mass. The 
tumor is tan white or fish flesh like appearance and frequently contains 
areas of hemorrhage and necrosis.
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Rhabdomyosarcomas6 are generally fleshy non descript pale gray-
yellow masses with areas of necrosis and hemorrhage. Of particular note 
is  the  gross  appearance  of  the  botryoid  variant  of  rhabdomyosarcoma 
because  of  its  resemblance  to  cluster  of  grapes.  The  tumor  arises 
exclusively along mucosa lined surfaces such as the bladder or vagina.
Non-Hodgkin  lymphomas8 generally  present  as  generalized 
lymphadenopathy  with   hepatosplenomegaly.  The  nodes  are  enlarged 
solid  homogenous  grey  mass  with  cut  surface  resembling  cut  potato 
appearance.
MICROSCOPIC FEATURES
At the time of incisional biopsy a frozen section diagnosis of small 
round cell  tumor,  identification of precise type deferred till  permanent 
section, is justified in most cases of SRCT.
In routine histologic sections, clues are provided by patterns and 
nuclear and cytoplasmic features2. (Table 4)
PATTERNS OF TUMOR CELLS
1. Diffuse – NHL, ES/PNET
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2. Well-developed nesting (lobular) pattern with fibro vascular 
septa (NB)
3. Filigree pattern or focal nesting pattern (ES/PNET)
4. Pseudofiligree pattern due to crust artifact (any SRCT)
5. Cambium layer in a polyploidy tumor (Botryoides sarcoma)
6. Myxoid pattern (Embryonal RMS)
7. Osteoid formation (Small cell Osteosarcoma)
8. Rare tubular structure ( Blastemal WT, small cell synovial 
sarcoma)
9. Well – developed rosettes (NB)
10. Ill – defined rosettes (FS/PNET)
11. Eosinophilic fibrillary background of neuropil(NB)
12. Alveolar pattern: Alveolar RMS (alveolar pattern is absent or 
only focally present in the solid variant of alveolar RMS)
13. Starry sky pattern (NHL, rarely NB)
14. Non – cohesive pattern (NHL)
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15. Desmoplasia (Desmoplastic SRCT)
16. Mucoid Background (Small cell Hepatoblastoma)
CYTOLOGICAL FEATURES
TABLE - 4
Feature SRCT in which the feature is 
characteristically seen.
Large round cells ES, large cell NHL, alveolar 
RMS
Spindle shaped or fusiform cells Embroynal RMS, rare cases of 
NB, ES/PNET, Blastemal WT
Convoluted Nuclei  Lymphoblastic NHL
Peripheral prominent nucleoli Large Cell NHL
Central Prominent nucleoli Immunoblastic NHL
Lymphoglandular bodies NHL
Mitotic Karryorrectic cells NB, NHL
Thin rim of basophilic cytoplasm Burkitt’s NHL
Thin rim of clear cytoplasm due to 
prominent glycogen content
ES / PNET
Vacuoles in cytoplasm Burkitt’s NHL
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There are small round cell  variants of tumors which are usually 
composed of spindle – shaped or fusiform cells (synovial sarcoma and 
MPNST).  There  is  also  a  well-  characterized  spindle  cell  type  of 
embryonal RMS.
The strongest  clue to the diagnosis of SRCT is provided by the 
differentiating (or rarely differentiated) cells, which may be sparse. These 
include:
a) Rhahdomyoblasts  and strap cells:  Showing dense  eosinophilic 
cytoplasm with cross striations.
b) Ganglion cells  or cells  intermediate between undifferentiated 
neuroblasts  and  ganglion  cells:  Cells  with  vesicular  nucleus, 
small neucleolus and discernible cytoplasm) in NB.
HISTOCHEMISTRY
Certain histochemical  features of the tumors may help to define 
cytological features.
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PAS  with   and   without   diastase  demonstrates  glycogen  in 
ES/PNET
Masson’s  trichrome  PTAH  demonstrates  cross-striations  of 
rhabdomyoblasts.
The current standard of practice of surgical pathology requires that 
the  precise  nature  of  tumor  cells  be  confirmed  by  more  definitive 
objective,  reproducible,  immunohistochemical  ultrastructural  and/or 
molecular biologic (genetic) markers.
IMMUNOCYTOCHEMISTRY IN DIAGNOSIS OF SMALL ROUND 
CELL TUMORS OF CHILDHOOD
Based upon clinical information, tumor site, touch preparations or 
possibly frozen section examination and SRCT antibody panel may be 
ordered at the time of gross examination, so that the tissue sections and 
immunocytochemical studies are initiated as soon as possible following 
tissue processing. Evaluation of the routinely stained permanent sections, 
allow for altering the antibody panel to confirm a specific tumor type or 
to eliminate other diagnostic categories not considered previous.
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The immunocytochemical  profiles  of  conventional  and extended 
spectrums  of  SRCTs  and  aberrant  immunoreactivily  of  SRCTs  are 
presented in tabular form.20-36 (Table – 5 & 6)
INITIAL ANTIBODY PANEL
Myogenin or Desmin
NB84 or Neuron specific Enolase
Leucocyte Common Antigen
CD99
Vimentin
Alpha fetoprotein
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TABLE - 5
ANTIBODIES AND IMMUNOREACTIVITY OF SMALL ROUND CELL 
TUMORS CHILDHOOD
Antibody
Tumors Typically 
Immunoreact with 
Antibody
Tumors may Immunoreact 
with Antibody
Leukocyte common 
Antigen
Lymphoid Leukemia, 
Lymphoma
Mesenchymal Chondrosarcoma
S-100 Protein Neuroblastoma, MPNST 
Ewings sarcoma /PNET
DSRCT, Hepatoblastoma, 
Wilms Tumor, Synovial 
sarcoma, Rhabdomyosarcoma 
Myofibroma, Mesenchymal 
chondrosarcoma, small cell 
Osteosarcoma
NB84 Neuroblastoma DSRCTs, ES
Neuron specific 
Enolase
Neuroblastoma, DSRCT Rhahdomyosarcoma, Ewings 
sarcoma
Myogenin Rhabdomyosarcoma DSRCTs, Wilms Tumor
Desmin Rhabdomyosarcoma, 
DSRCT
Wilms Tumor / MPNST, 
Rhabdoid Tumor
Muscle specific Actin Rhabdomyosarcoma, 
Myofibroma
DSRCT, Wilms tumor, 
Rhabdoid tumor, MPNST
CD99 Ewings Sarcoma /PNET Leukemia, Lymphoma, RMS, 
DSRCTs, Synovial sarcoma, 
Mesenchymal chondrosarcoma
Pancytokeratin Synovial sarcoma, Hepato 
blastoma, Carcinoma, 
Rhabdoid Tumor, Germ 
cell tumors, DSRCT
Ewings sarcoma, RMS, 
Leukemia, lymphoma
Alpha – Fetoprotein Hepatoblastoma, 
Endodermal sinus tumor 
(Yolk sac Tumor)
Myeloperoxidase Myeloid Leukemia
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Antibody panels for defining origin of undifferentiated SRCT20-36.
Myogenic: Desmin
Myogenin
Muscle Specific Actin
Neural: NB84
Neuron specific endase
S100
Lymphoid:   Leukocyte Common Antigen
Myeloperoxidase protein
Germ Cell:  Alpha feloprotein
 Pancytokeratin
Neural Crest:   S100 Protein
    HMB-45
    CD99
Mesenchymal:  Vimentin
      Smooth muscle Actin
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TABLE - 6
CONVENTIONAL SPECTRUM OF SRCTs: IHC 
IMMUNOREACTIVITY
Typical Possible Aberrant
Neuroblastoma NB84
Neuron specific enolase
Chromogranin
Synaptophysin
S-100 Protein
Leu 7(CD57)
Glial Fibrillary Protein
Neural cell Adhesion 
Molecule
Ganglioside G-D2
Neurofilament Triple 
protein
Microtubule 
Associated Protein
Dopamine
Peripherin
Vasoactive Intestinal 
Protein
Protein Genen product 
9.5
Myelin Basic Proein 
Trk - A
Vimentin
ES/PNET CD99
Beta 2 microglobulin
Vimentin
Acetylcholine
S-100 Protein
Neuron Specific 
Enolase
Neurofilament Triple 
Protein
Synaptophysin 
Leu7(CD57) 
Chromogranin Glial 
Fibrillary Acid Protein
Neurofilament Triple 
protein
Pancytokerati
n
Desmin
MSA
EMA
NB84
TrkAu
Rhabdomyosarc
oma
Myogenin
Desmin
MSA
MyoD1 
Vimentine
SMA
Dystrophic
Creatine Kinase M 
Subunit
Calsequestrin
Myf-3 and Myf-4 
Myoglobin
S100 Protein
Pancytokerati
n
CD19/CD20/ 
CD99
EMA
NSE
Leu7(CD57)
CD68
Trk A
Non Hodgkins  
Lymphoma/Lymp
hoid Leukemia
Leukocyte common 
antigen
CD3/CD4/CD8/CD45 
RO(T-Cell)
CD19/CD20/CD79a (B-
Cell)
ALK-NPM(ALK-1-
P80)
CD-30(Ki-1,BerH2).
Vimentin
Cytokeratin
EMA
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ANTIBODIES  ASSOCIATED  WITH  CHIMERIC  AND  TUMOR 
SUPPRESSOR PROTEINS
Several  antibodies capable  of  detecting cytogenetic  translocation 
and tumor suppressor proteins are available for formalin-fixed, paraffin 
embedded tumor tissues.  Recently antibodies (ALK-1 and P80) to  the 
chimeric  protein  produced  by  the  translocation  [t(2:5),  AI-NPM] 
associated  anaplastic  large  cell  lymphoma  may  provide  a  means  for 
expected  diagnosis  via  immunocytochemistry  2.  The  mutated  tumor 
suppressor WT-1 has been identified in 40% of Wilm’s tumors and a large 
proportion  of  DSRCTs.  P53 protein  overexpression in  several  SRCTs, 
including rhabdomyosarcoma and Wilms tumor has been associated with 
unfavourable  histology,  recurrences,  metastatic  disease  and  decreased 
survival. Over expression of the retinoblastoma gene protein, PRB, may 
be seen in SRCTs and may have diagnostic value in certain tumors such 
as small cell (Undifferentiated) osteosarcoma.
PROLIFERATION MARKERS
Many  proliferation  markers  associated  with  the  cell  cycle  have 
unfavorable  prognostic  significance20,31,34,36,37.  The  overexpression  of 
MIB1(Ki-67), PCNA, bcl-2, p15, p16 and cyclin dependent kinases are 
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associated with higher grade and stage of tumor, as well as unfavorable 
outcome. In the future, semi quantitative and more rigorous quantitative 
analysis of tumor suppressor gene products and cell cycle proliferation 
markers may become a standard of care.
ELECTRON MICROSCOPY IN SRCTS
Even  when  a  pediatric  round  cell  tumor  appears  completely 
undifferentiated  upon  light  microscopy,  ultrastructural  diagnosis  is 
normally  quite  simple  and  straightforward.  The  characteristic  ultra 
structural features of SRCTs include the following38,39,40,41 (Table-7)
ULTRA STRUCTURAL DIAGNOSTIC FEATURES
TABLE - 7
Intercellular 
junctions
External 
Lamina Glycogen
Neurosecretory 
granules Myofilament
NB + - - + -
RMS - + + - +
ES/PNET + - + +*
-
-
NHL - - - - -
*A few neurosecretory granules may be present in PNET.
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IMMUNOHISTOCHEMISTRY VS ELECTRON MICROSCOPY
Electon  microscopy  like  standard  light  microscopy  provides  a 
direct  morphological  approach and is therefore the most  powerful  and 
least treacherous of the many ancillary diagnostic techniques available33. 
While other  ancillary techniques [eg.  IHC,FISH,PCR] are restricted in 
application  to  hypothesis  testing  electron  microscopy  can  provide  a 
correct answer even when the wrong question or no specific question is 
being asked. This having been said it must be stressed that each of these 
special  techniques  has  its  relative  strength  and weakness  in  particular 
situations44,45.These should not be considered as competitive techniques 
but rather as complementary tools, which are best employed using a fully 
intergrated approach.
MOLECULAR PATHOLOGY OF SRCTS
Molecular  markers  have  been  increasingly  used  as  a  diagnostic 
tools as well as indicators for prognosis. Molecular markers that are used 
to diagnose a SRCT is given below46-54. (Table – 8)
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TABLE - 8
MOLECULAR MARKERS USED IN DIAGNOSIS & PROGNOSIS 
OF SRCTS
Tumor Marker Locus/Translocation Comments/Techniques
NB MYCN 2p24 Amplification (> 10 copies), poor 
prognosis, usually associated with 
high stage disease; PCR or southern 
blot.
NB Del 1p 1p3l-1p32 Associated with high stage disease; 
smaller deletion associated with more 
favorable outcome; PCR
ES/PNET EWS/FLI-1 (11,22)(q24; 
q12)
Found in upto 90% cases; Types I and 
II fusion products most common; 
Type I more favorable; RT-PCR
ES/PNET EWS/ERG (21,22)
(q22:q21)
Found in up to 5% of cases; RT-PCR
NHL, B-Cell 
type
IgH 14q32 Gene rearrangements identified in > 
90% of cases; PCR or southern blot
NHL, T-Cell 
type
TCR or 7q34 or 7p15 Rearrangements identified in majority 
of cases; PCR or Southern blot
Wilms Tumor WT1 11p13 Mutations occur in both sporadic and 
hereditary Wilms Tumors; PCR
DSRCT EWS/WT-1 (11,22) 
(q113; q12)
Only found in DSRCT; RT-PCR
Alveolar 
Rhabdomyosar
coma
PAX3/FKHR (2; 13)(Q35; 
q14)
Found in upto 70% of cases; 20% 
cases have t(1:13)(p36;q14), 
PAX7/FKHR associated with better 
prognosis; RT-PCR
Synovial 
sarcoma
SYT/SSX (X:18)
(P11:Q11)
80% of cases; SYT/SSX1 in biphasic 
sarcomas. SYT/SSX2 in monphastic 
type associated with better prognosis: 
RT-PCR
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In addition to the molecular markers outlined in this table for broad 
groups of  B and T cell  NHL, numerous  abnormal  translocations  with 
fusion of genes and resulting fusion transcripts have been demonstrated in 
specific subtypes of B and T cell NHL.
UNCLASSIFIABLE TUMORS
A large  observer-blinded  study  comparing  the  utility  of  various 
techniques  in  the  diagnosis  of  undifferentiated  pediatric  –  round  cell 
tumors34,35 demonstrated  that  immunohistochemistry  and  electron 
microscopy  when  used  in  combination  can  be  expected  to  produce  a 
confident specific diagnosis in 96% of cases. The additional application 
of cytogenetic and molecular diagnostic techniques produced a diagnosis 
in another two percent. Thus it may be accepted that in rare instances, 
despite  all  efforts,  a  tumor  will  have  to  be  categorized  as 
“Unclassifiable”55. 
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MATERIALS AND METHODS
The surgical specimens received in the department of Pathology, 
Institute  of  Child  health,  Egmore  from the  surgical  department  of  the 
same institute during the period of 2007 Jan to 2008 December formed 
the material  for  this  study.  Small  biopsy specimens and total  excision 
specimens were included.
The clinical  features such as age and sex of  the patient,  site  of 
lesion and type of surgery done were noted.
The gross characteristics of the tumor included the tumor location, 
size,  necrosis   circumscription,  cut  section  and  secondary  changes 
directly from the specimens.
Paraffin  blocks  were  made  and  histological  sections  (5  to  6 
micrometer)  were routinely stained with hematoxylin and eosin stains. 
Microphotographs  were  taken.  IHC stains  were  done  wherever  found 
necessary.
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PROCEDURES
HEMATOXYLIN AND EOSIN
1. Dewax sections, hydrate through graded alchols to water.
2. Stain in Harris Hematoxylin for 5 minutes
3. Wash well in tap water
4. Diffentiate in 1% acid alcohol
5. Wash  well  in  tab  water  until  sections  are  again  blue  for  10-15 
minutes
6. Stain in 1% eosin for 1 to 2 minutes
7. Wash in running tap water for 1 to 5 minutes
8. Dehydrate the alcohols clearly in Xylol and mount in DPX.
MICROSCOPIC FEATURES
The microscopic features were studied from all the available slides. 
These included the histological pattern, cellular features, pleomorphism, 
mitosis, vascularity and secondary changes. Diagnosis were made.
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SPECIAL STAINS
Periodic Acid Schiff Stain (Glycogen in ES/PNET)
Method:
1. Dewax sections and bring to distilled water
2. Treat with periodic acid for 5 minutes
3. Wash well with several changes of dilateted water
4. Cover with Schiff’s solution for 15 minutes
5. Wash in running tap water 5-10 minutes
6. Stain nuclei with Harris Hematoxylin. Differentiate as appropriate 
in acid alcohol and blueing in tapwater  for 5 minutes.
7. Wash in water
8. Rinse in absolute alcohol
9. Clear in Xylene and mount with DPX
RESULTS
Glycogen :  Magenta
Nuclei : Blue
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IMMUNOHISTOCHEMISTRY
Cases  for  IHC were  selected  after  viewing  the  H &E sections. 
Slides were coated with chrome alum, and subjected to Antigen Retrival 
using the Microwave technique with Citrate buffer solution .Slides were 
then treated by HRP (Horse radish peroxidase) polymer technique.
HRP POLYMER TECHNIQUE
The coated slides were taken through the following steps
1. Treatment with peroxidase block – for incubation of endogenous 
peroxidase in the tissue for 20 minutes, washed in PBS buffer for 
5 mts.
2. Applications of power block O- to block non specific antigen – 
antibody reactions for 20 minutes. The excess power block was 
blot dried. 
3. Applications  of  Primary  antibody  –  Murine  antibodies  for  60 
minutes. Washed in PBS buffer for 5 minutes.
4. Application of super enhancer for 30 minutes which increased the 
sensitivity  of  antigen  -antibody  reaction  thereby  enhancing  the 
final reaction product.
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5. Application of SS label – Secondary antibody from goat with the 
tagged horse radish peroxidase enzyme for 30 minutes. Washed in 
TRIS buffer.
6. Application  of  DAB  (Diamino  benzidine)  Chromogen  for  5 
minutes – which was cleared by the enzyme to give the colored 
product at antigen sites. Washed in distilled water for 5 minutes.
7. The  slides  were  then  counter  stained  with  hematoxylin  .Slides 
were air dried and mounted with DPX (Dibutylphalate Xylene)
The following markers were done
CD45, CD3, CD20, CD99, Cytokeratin, S-100, Synaptophys in and 
Chromogranin.
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OBSERVATION AND RESULTS
INCIDENCE
The total number of 194 neoplastic lesions were reported during 
the period of  2 years, 2007 –2008. The distribution of the tumors is given 
in the following Table – 9 (Fig.2). 
TABLE - 9
System No of Cases
Lymphoreticular 74
Gastro Intestinal Tract and 
Hepatobilliary
12
Endocrine 2
Renal 34
Soft Tissues 10
Bone 9
Germ cell tumors 25
RS 1
Sympathetic system 27
Total 194
Among these Small Round Cell Tumors constituted 72 cases. 
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The Small  Round Cell  Tumors included the following Table  – 10, 
(Fig.4):
TABLE - 10
Tumor Type No of Cases Percentage (%)
Non Hodgkins Lymphoma 37 51
Neuroblastoma 20 28
Ewings/PNET 11 15
Rhabdomyosarcoma 3 4
Wilms Blastemal 
Predominant
1 1
Total 72 100
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Non Hodgkins Lymphoma constituted almost 50% of the tumors 
followed by Neuroblastoma and Ewings sarcoma.  Rhabdomyosarcoma 
constituted only 4% and  Blastemal predominant Wilms constituted 1 %.
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AGE DISTRIBUTION
Age of the patients with SRCTs ranged between < 1 Yr to 12 Yrs, 
in which 2/3rd of the cases were less than 5 Yrs (Table – 11, Fig.5).  
TABLE - 11
Age Group No. of Cases Percentage (%)
<1 to 5 47 66
6 to 10 24 33
>10 1 1
Total 72 100
FIGURE - 5
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SEX RATIO
Among the 72 cases 40 were male patients and 32 were female. 
Thus there was a slight male predominance (Table 12).
TABLE - 12
Sex No. of cases Percentage
Male 40 55.6
Female 32 44.4
Total 72 100
FIGURE - 6
Male
Female
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Sex Ratio
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NON HODGKINS LYMPHOMA (NHL)
NHL constituted the most common tumor among the SRCTs with 
37 cases out of the total 72 cases. Children of age group 2 to 5yrs were 
most commonly affected, the youngest being a one year old child (Table – 
13). There was a male preponderance (Table – 14).
TABLE - 13
Age Cases
1  to 5 22
6 to 10 14
> 10 1
Total 37
SEX RATIO
TABLE - 14
Male Female
28 9
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SYMPTOMS AND SIGNS
Children commonly presented with generalized lymphadenopathy. 
5 of them presented with a mass abdomen.Fig.7 shows a tumor involving 
the  small  intestine.  Fig.8,  9  and 10 show the  microscopic  features  of 
marginal zone B cell  lymphoma.  1 patient presented with a testicular 
mass,  whose  peripheral  smear  and  bone  marrow  examination  were 
normal. 1 child was a known case of ALL in remission who developed 
inguinal lymphadenopathy. On light microscopy a diagnosis of NHL was 
made. On IHC study it was found to be peripheral T cell lymphoma. 
NEUROBLASTOMA
This was the second common SRCTs constituting around 28% of 
cases. Predominantly seen in  age  group of less than 5 yrs, among which 
5 of them were less than 1yr (Table - 15. The youngest  being a child 
presented with progressive distention of the abdomen from 10 days of 
birth. There was a female preponderance (Table – 16).
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TABLE - 15
Age Cases
1  to 5 17
6 to 10 3
> 10 0
Total 20
SEX RATIO
TABLE - 16
Male Female
6 14
Among  the  20  cases  13  of  them were  adrenal  neuroblastomas. 
They  usually  presented  as  mass  abdomen.  Fig.21  shows  adrenal 
Neuroblastoma  infiltrating  the  adjacent  renal  parenchyma.  One  was  a 
posterior mediastinal mass and two others presented as sacrococcygeal 
masses.  Four  cases  were  metastatic  deposits,  two  of  them  in  the 
lymphnodes, one in the liver and the other in the bone marrow. Grossly 
they  had  an  average  size  of  5  x  5  cms  with  a  bosselated  external 
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appearance and the cut surface showed a homogenous whitish solid mass. 
On light  microscopy they showed small  round cells  arranged in 
true  rosettes  around  central  neuropil  with  schwanian  stroma  and 
calcifications. Most of the cases were poorly differentiated. Fig.22,23 and 
24 show the microscopic features.
EWINGS/PNET
EWINGS sarcoma formed the third common sarcoma in the study, 
constituting 11 cases. There was a female preponderance, and the average 
age  of  children  affected  being  7  to  8  years  (Table  –  17  & 18).  The 
youngest being a 3 month old child. More than 50% presented with chest 
wall  swelling.  Others  with  swelling  in  the  extremities  and  paranasal 
sinuses. 
TABLE - 17
Age Cases
1  to 5 4
6 to 10 7
> 10 0
Total 11
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SEX RATIO
TABLE - 18
Male Female
4 7
On light microscopy the tumor cells are seen arranged in sheets, 
cords, filigree pattern. Fig.17 and 18 show the tumor cells arranged in 
nests separated by thin fibrous septae. The tumor exhibits dual population 
of  neoplastic  cells,  small  round  cells  with  dark  nuclei  and  scant 
cytoplasm and large polygonal cells with abundant clear cytoplasm and 
vesicular  nucleus.   Ill  formed  rosettes  were  also  seen.  Large 
fibrocollagenous and fibrillary stroma was seen in the background. PAS 
stain studied showed focal positivity.
RHABDOMYOSARCOMA
They constituted 3 cases among the 72 cases. All the children were 
less than 5 yrs old with a female preponderance (Table – 19 & 20). They 
presented with a swelling in extremities and head and neck. 
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TABLE - 19
Age Cases
1  to 5 3
6 to 10 0
> 10 0
Total 3
SEX RATIO
TABLE - 20
Male Female
1 2
On light microscopy 2 of them showed alveolar RMS and one was 
embryonal RMS. Fig.29 shows the alveolar pattern of tumor cells and 
Fig.30 shows rhabdomyoblast differentiation of the tumor cells.
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BLASTEMAL PREDOMINANT WILMS TUMOR
Only one case diagnosed amongst 72 cases. It was a nephrectomy 
specimen from a 3 yr old boy. On light microscopy it showed a neoplasm 
arranged in nodules separated by spindle shaped stromal elements. The 
tumor  cells  were  small  round  with  dense  nuclei.  Few  areas  showed 
atrophic tubules. Fig.31, 32 and 33 show the microscopic features. Hence 
a diagnosis of Blastemal predominant wilms tumor was arrived at.
Immunohistochemistry was done randomly in 20 cases. Panel of 
CD99,  LCA,  CD20,  CD3  and  Cytokeratin  were  done  to  confirm 
EWINGS/PNET by  histomorphology.  Lymphoma  panel  comprising  of 
CD45,  CD20  and  CD3  were  done  to  confirm  Non-Hodgkin’s 
lymphoma.In  2  cases  of  Neuroblastoma  a  panel  comprising  of 
chromogranin,  synaptophysin  and  S100  were  done  to  confirm  the 
diagnosis. Fig.5,6 and 9 show the positivity of CD45. Fig.7 and 10 show 
the membrane positivity of CD20.Fig. 13 and 14 show CD99 exhibiting 
membrane positivity.Fig.20,21 and 22 show the cytoplasmic positivity of 
S100, synaptophysin and chromogranin.
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TUMORS IN WHICH IMMUNOHISTOCHEMISTRY HELPED IN 
CONFIRMING THE DIAGNOSIS
Case  1: 619/07,  10yrs  old  female  child  presented  with  mass 
abdomen with lymphnode enlargement in the right supraclavicular and 
suprascapular region. On histopathological examination of the lymphnode 
a neoplasm arranged in cords and nests separated by fibrocollagenous and 
fibrillary  stromawas  seen.A diagnosis  of  small  round  cell  tumor  was 
arrived at and IHC was suggested  for confirmation. Following markers 
were done (Table – 21). 
TABLE - 21
Markers Results
CD99 Positive
Vimentin Positive
MSA Negative
Desmin Focal Positive
Synaptophysin Focal Positive
CD45 Negative
Consistent with Ewings sarcoma/PNET
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Case  2: 806/07  3yr  male  child  presented  with  axillary 
lymphadenopathy.  X ray chest  revealed mediastinal  widening. Axillary 
node biopsy revealed diffused proliferation of lymphocytes, eosinophils 
and binuclear histiocytes. Hence the diagnosis of Hodgkins lymphoma 
was arrived at. Following markers were done (Table – 22). 
TABLE - 22
Markers Results
CD45 Focal Positive
LMP Negative
CD5 Negative
CD20 Focal Positive
ACK-1 Positive
CD3 Negative
EMA Positive
CD30 Positive
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Consistent with Anaplastic large cell lymphoma
Case  3: 631/08  A  7yr  female  child  presented  with  cervical 
lymphadenopathy. Lymphnode on histopathological examination showed 
features suggestive of chronic non specific lymphadenitis.However IHC 
was  suggested  to  rule  out  lymphiproliferative  disorder.  Following 
markers were done (Table – 23). 
TABLE - 23
Markers Results
CD3 Positive
CD45 Positive
CD20 Negative
CD79a Negative
Ki67 40 – 50%
Tdt Positive
CD99 Positive
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Consistent with T-cell lymphoblastic lymphoma/leukemia.
Case 4: 815/08 5yr male child presented with swelling in the right 
mandible region. X-ray mandible showed a lytic leision with soft tissue 
swelling. Histopathologic examination revealed a neoplasm arranged in 
sheets  and  attempted  rosettes  in  a  fibrillary  background.  Hence  a 
diagnosis of small round cell tumors, probably Neuroblastoma/PNET was 
arrived at. Following markers were done (Table – 24). 
TABLE - 24
Markers Results
CD45 Positive
Vimentin Focal Positive
CD56 Negative
Desmin Negative
Synaptophysin Negative
CD99 Negative
CD20 Positive
Ki-67 Increased, 56%
CD79a Positive
Tdt Negative
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Consistent with High grade B lineage Non Hodgkins lymphoma
Case 5: 380/08 8yr old female child presented with retroperitoneal 
mass.  X-ray  revealed 12th rib  sclerotic  changes.  Incisional  biopsy  was 
done. Histopathologic examination showed a neoplasm composed of cells 
arranged  in  lobules  separated  by  fibrous  septa.  Impression  was  small 
round cell tumor suggestive of Ewings sarcoma was arrived at. Following 
markers were done (Table – 25). 
TABLE - 25
Markers Results
CD99 Positive
Vimentin Positive
CD45 Negative
Cytokeratin Negative
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DISCUSSION
There  has  been  enormous  progress  in  the  treatment  of 
childhood cancer described. Hitherto, it is essential to systematically 
study the burden of childhood cancer in India and to understand how 
the occurrence and outcome of the disease varies across the country. 
A comprehensive  review of  medical  literature  revealed  that  1.6  to 
4.8% of all cancer in India is seen in children below 15 years of age 
and the overall incidence of 38 to 124 per million children, per year, is 
lower than that in the developed world. There is considerable inter-
regional variation in    incidence and mortality rates across India, this 
suggests  a  possible  deficiency in ascertainment  of  cases and death 
notification,  particularly  in  rural  areas.  The  marked  male 
preponderance  of  Hodgkin's  disease,  lower  incidence  of  central 
nervous system tumors, and higher incidence of retinoblastoma merit 
further analysis.
In the Institute of Child Health the most common malignancy 
was Lymphomas, followed by germ cell tumors and Wilms tumor.
Pediatric  small  round  cell  tumors  comprise  a  group  of  diverse, 
diagnostically  challenging  primitive  or  undifferentiated  neoplasms. 
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Precise  diagnosis  of  the  tumor  type  is  necessary  for  selection  of 
appropriate treatment protocol.
Small Round Cell tumors constitute about 20% of the solid tumors 
in children. In this study the SRCTs constituted around 37%.This again 
because CNS tumors were not  included,Taken collectively  lymphomas 
are the third most common childhood malignancies after acute leukemias 
and brain tumors. It has a male predilection. This study substantiates tha 
fact.In this study NHL was the predominant tumor type constituting 37 
cases.  They  formed  51%  of  the  total  cases.  There  was  a  male 
predominance with a M:F ratio 3.1:1 Children commonly presented with 
generalized lymphadenopathy. 5 of them presented with a mass abdomen. 
1 patient presented with a testicular mass, whose peripheral smear and 
bone marrow examination were normal. 1 child was a known case of ALL 
in  remission  who  developed  inguinal  lymphadenopathy.  On  light 
microscopy a diagnosis of NHL was made. On IHC study it was found to 
be peripheral T cell lymphoma. 
Neuroblastoma is the third most common malignant tumor and the 
most  common  extracranial  solid  tumor,  with  a  male  predilection, 
generally diagnosed in early childhood, 50% are below 2yrs and 90% 
below 5yrs x. In this study also Neuroblastoma was the second common 
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small  round  cell  tumor.  Among  the  72  cases,  20  cases  were 
Neuroblastoma,  thus  constituting  around  38.5%  of  all  the  SRCTs. 
Neuroblastoma involved children of age less than 5 years predominantly. 
5  of  them were  less  than  one  year.  The  youngest  being  a  child  who 
presented with progressive distention of abdomen from the 10th day of 
birth. However there was a female preponderance with 14 cases among 
the 20 cases.This  was against  the fact  that  Neuroblastomas have male 
predominance in  studies by Enzinger et al and others.
Most of the cases were adrenal neuroblastomas presenting as mass 
abdomen.  One was a  posterior  mediastinal  mass.  Two other  presented 
with sacrococcygeal mass. 16 cases  were primary neuroblastomas while 
4  were  secondary  metastatic  deposits  to  lymphnodes,  liver  and  bone 
marrow.This goes well proved aspects of Neuroblastoma.
Ewings sarcoma formed the third common sarcoma in the study, 
constituting 11 cases. There was a female preponderance againt the male 
predominance  in other studies  and the average age of children affected 
being 7 to 8 years which goes well with oter studies. The youngest being 
a 3 month old child. More than 50% presented with chest wall swelling. 
Others with extremities and paranasal sinuses. 
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Rhabdomyosarcoma  is  the  most  common  pediatric  soft  tissue 
sarcoma  comprising  80-90%  of  reported  sarcomas.  Usually  affects 
children before the age of 10yrs with a peak before the age of 4yrs. It has 
a male predilection (Fletcher).  In our study it constituted 3 cases among 
the 72 cases.  All  the children were less  than 5 yrs  old with a  female 
preponderance. They presented with a swelling in extremities and head 
and neck.
Wilms tumor with blastemal predominance has a histomorphology 
of small round cell tumor which leads to difficulty in diagnosis. In this 
study  only  one  case  was  identified  amongst  72  cases.  It  was  a 
nephrectomy  specimen  from  a  3  yr  old  boy.  On  light  microscopy  it 
showed  a  neoplasm arranged  in  nodules  separated  by  spindle  shaped 
stromal elements. The tumor cells were small round with dense nuclei. 
Few  areas  showed  atrophic  tubules.  Hence  a  diagnosis  of  Blastemal 
predominant wilms tumor was arrived at.
Role of IHC
In many instances, the combination of the clinical presentation and 
the light microscopic appearance is sufficient to make a diagnosis. For 
example,  a  tumor  in  a  baby  with  an  adrenal  mass  and  elevated 
catecholamine  levels,  which  microscopically  reveals  neuroblasts, 
background neuropit, calcifications, and thin fibrovascular septa, can be 
comfortably diagnosed as a Neuroblastoma. However, an undifferentiated 
rhabdomyosarcoma  may  require  immunohistochemistry  or  molecular 
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analysis to confirm the skeletal muscle differentiation of the tumor. The 
decision  about  when  to  order  these  special  studies  depends  on  the 
complexity of the tumor.
In  this  study the  most  challenging  was  to  differentiate  betweenNon  Hodgkins 
Lymphoma and  Ewings  Sarcoma.Neuroblastoma and Rhabdomyoblastomas  had 
typical  histomorphology.The help  of  IHC was saught  to  differentiate  NHL and 
Ewings.
  An initial limited panel is often the first step toward refining or 
confirming the diagnosis. If this results in unexpected findings, a second, 
more comprehensive panel may then be used. In both cases, however, a 
multiple antibody panel is usually used as reliance on one antibody can 
be misleading. For example, desmin-positive PNETs and CD99 positive 
synovial sarcomas are known to occur.
Interpretation of IHC findings requires proper understanding of the 
nature of expression of various markers in each tumors. Certain SRCTs 
express antigens based upon their degree of differentiation. For example 
with rhabdomyosarcoma, many different muscle precursor antibodies are 
available and may be needed for diagnosis due to the variable degree of 
myogenic  differentiation  in  these  tumors.  Myogenic  regulator  gene 
proteins (myogenin, myoD1, mfy-3, myf-4) will be expressed as nuclear 
antigens at an earlier phase of muscle protein differentiation than those 
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associated  with  later  cytoplasmic  myogenic  maturation  (myoglobin). 
Myogenin,  myoD1,  poyclonal  desmin,  and  muscle  specific  actin  are 
expressed  in  over  90%  of  rhabdomyosarcomas;  while,  myoglobin  is 
expressed  variably  (29  to  78%).   In  contrast,  less  than  5%  of 
rhabdomyosarcomas immunoreact with smooth muscle actin.
Aberrant expression is not unusual in SRCTs. Rhabdomyosarcoma 
may  be  particularly  troublesome,  because  CD99,  CD19,  CD20, 
cytokeratin and NSE may also be aberrantly expressed.  This may lead to 
errant  diagnoses  of  B-cell  leukemia/lymphoma,  Ewings  sarcoma  and 
Neuroblastoma in some cases of rhabdomyosarcoma that do not express 
typical  myogenic  marker.  Tumors  mimicking  the  light  microscopic 
appearance  of  rhabdomyosarcoma,  such as  extra-renal  rhabdoid  tumor 
may require the addition of other markers (cytokeratin, EMA, vimentin in 
the case of rhabdoid tumor) to provide a definitive diagnosis.  Lack of 
expression of tumor defining antigens may occur in SRCTs. For example 
in  one  subtype  of  rhabdomyosarcoma  (undifferentiated  sarcoma), 
vimentin may be the only tumor marker identified.
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There  is  considerable  cross-reactivity  among  various  neoplasms 
and antibodies.  For example, CD99 (MIC2) is not specific to Ewings 
sarcoma  family  of  tumors  alone.  In  fact,  the  following  SRCTs 
immunoreact with CD99: lymphoblastic leukemia and lymphoma with a 
cytoplasmic pattern depending upon the lineage (60% unknown lineage, 
75%  B  progenitor  lineage,  100%  T-cell  lineage);  desmoplastic  small 
round  cell  tumor  (DSRCT)  with  a  membrane  pattern.  (DSRCT  is 
characteristically  polyphenotypic  and  immunoreacts  with  desmin  in  a 
“dot-like” or “globoid” pattern, neuron specific enolase and cytokeratin.) 
DSRCTs lacking desmin and cytokeratin staining may be mistaken for 
extraosseous  Ewings  sarcoma.  Immunoreaction  with  WT-1  may  be 
helpful in defining a DSRCT that does not express myogenic or epithelial 
markers and could be confused with Ewings sarcoma. A  definitive 
diagnosis  can  be  made  on  the  basis  of  clinical,  basic  histologic  and 
ancillary studies in virtually all cases of SRCTs. The critical aspects for 
accurate diagnosis of SRCT are adequate clinical data, adequate size of 
biopsy of tumor, expecting the unexpected if there are unusual clinical 
presentations  (NHL  arising  in  a  bone  or  soft  tissue,  Burkitt’s  NHL 
presenting  as  small  duodenal  mucosal  nodules)  and  apparent  or  real 
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discrepancies in the results of pathologic studies of biopsy and getting 
ancillary studies done.
Diagnosis of the precise type of SRCTs is rarely made on the basis 
of  a  single  characteristic  feature.  Clinical  and  routine  histopathologic 
features and results of ancillary studies are all taken into consideration. 
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SUMMARY AND CONCLUSION
During the period of study between  January 2007 and December 
2008  tumors  with  histomorphology  of  small  round  cells  were  taken 
up.194  neoplastic  lesions  were  reported  and  among  which  SRCTS 
constituted 72 cases.
Among  the  SRCTs,Non  Hodgkins  Lymphoma  was  the  most 
predominant type with 37 out of 72 cases, followed by Neuroblastoma 
with 20 cases, Ewings Sarcoma with 11 cases  and  Rhabdomyosarcoma 
with 3 cases.
Small Round Cell Tumors are commonly seen in children less than 
10 years of age. The youngest was a 10 day old child diagnosed with 
Neuroblastoma followed by a 3 month old child with Ewings, 6 month 
old child with Rhabdomyosarcoma and 1 year old child with NHL. NHL 
had  male  predominance  as  in  other  studies.  However  Neuroblastoma, 
Ewings  and  Rhabdomyosarcomas  had  female  predilection  against  the 
male predominance in previous studies. 
Histomorphology  was  sufficient  to  diagnose  most  cases. 
Difficulties  were  faced  in  differentiating  Ewings  from  NHL  and  to 
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differentiate NHL and HL.
Ancillary  studies  like  IHC  plays  a  key  role  in  confirming  a 
diagnosis. IHC markers CD45, CD20 And CD3 confirmed lymphomas, 
CD99  proved  Ewings  and  Chromogranin,  S-100  and  Synaptophysin 
confirmed Neuroblastoma. However the limitations of IHC like aberrant 
expression of antigens and cross reactivity with other antigens should be 
kept in mind.
SRCTs  are  amongst  the  commonest  solid  tumors  of  childhood. 
They comprise a group of diverse, diagnostically challenging primitive or 
undifferentiated neoplasms,Precise diagnosis of the SRCTS depends on 
the  clinical  routine  histopathologic  features  and  results  of  ancillary 
studies like immunohistochemistry, electron microscopy, flow cytometry 
and molecular analysis. 
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MASTER CHART
S.
No.
HPE
No. Age Sex Site HPE Diagnosis
1 1/07 6 M Cervical LN NHL-High grade
2 15/07 3 M Mass abdomen NHL-High grade
3 21/07 8/12 M L forearm mass Ewings sarcoma
4 24/07 8 F L forearm mass Ewings/PNET
5 141/07 4 F
Mass abdomen, 
Mesenteric LN NHL-High grade
6 170/07 1 1/2 M Mass abdomen
Neuroblastoma 
differentiating
7 193/07 5 M
Axillary & Inguinal 
nodes NHL-High grade
8 203/07 12 F Mass abdomen NHL-Diffuse large cells
9 222/07 2 1/2 F R chest mass PNET
10 243/07 4 F Bone marrow
Neuroblastoma-secondary 
deposits bone marrow
11 254/07 3 1/4 F Mass abdomen NHL-High grade
12 269/07 3 F L maxillary swelling ERMS
13 279/07 4 M R chest wall LN NHL-High grade
14 416/07 5 F Mass abdomen NHL-High grade
15 458/07 6 F Generalized LN NHL-Diffuse large cell
16 464/07 7 M Cervical LN NHL-High grade
17 465/07 1 F Generalized LN NHL-Diffuse large B cell
18 545/07 7 M Generalized LN NHL-High grade
19 559/07 6 M L adrenal tumor
Neuroblastoma 
differentiating
20 601/07 9 F Mass abdomen
Neuroblastoma 
differentiating
21 606/07 7 M Axillary nodes NHL-Diffuse larger B cell
22 619/07 10 F R chest wall mass PNET
23 631/07 5 M Testicular mass NHL-Diffuse large B cell
24 729/07 33/365 M
Liver biopsy, mass 
abdomen Neuroblastoma
25 806/07 3 M
L axillary node bx, 
Generalized LN
Anaplastic Large cell 
Lymphoma
26 880/07 7 M Generalized LN NHL High Grade
27 922/07 4 1/2 F R adrenal mass
Adrenal Neuroblastoma 
undifferentiated
28 926/07 5 M Cervical LN NHL-High grade Burkitts
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S.
No.
HPE
No. Age Sex Site HPE Diagnosis
29 1034/07 1 1/4 M Mass abdomen Neuroblastoma
30 1052/07 2 1/2 M Sacrococcygeal mass
Neuroblastoma 
undifferentiated
31 1086/07 9 F L chest wall mass PNET
32 1170/07 5 F Paraaortic nodes NHL- Diffuse large B cell
33 1321/07 4 1/2 M Mass abdomen NHL-High grade
34 1349/07 2 1/2 M Adrenal mass
Neuroblastoma poorly 
differentiated
35 1368/07 11 F R clavicle Ewings sarcoma
36 1393/07 10 M L inguinal nodes NHL-High grade
37 1422/07 1 1/2 F Ladrenal mass
Neuroblastoma poorly 
differentiated
38 1427/07 7 F Generalized LN NHL-Diffuse large cell
39 16/08 10 M Generalized LN NHL-Diffuse large B cell
40 23/08 4 M R calf muscle posterior Alveolar RMS
41 73/08 4 1/2 F Mass abdomen
Neuroblastoma poorly 
differentiated
42 78/08 4 M Mass small bowel NHL High grade
43 85/08 10 M Generalized LN NHL-High grade
44 88/08 1 M L lumbar mass
Neuroblastoma 
undifferentiated
45 100/08 4 M R cervical LN NHL-High grade
46 227/08 1 F Presacral mass
Neuroblastoma poorly 
differentiated
47 287/08 1 F Pelvic mass
Neuroblastoma 
differentiated
48 380/08 8 F Retroperitoneal mass Ewings sarcoma
49 396/08 3 M Generalized LN NHL
50 458/08 7 M Cervical LN NHL-High grade
51 480/08 7 M Chest mass Ewings / PNET
52 517/08 5 M Generalized LN NHL-High grade
53 566/08 7 M Generalized LN NHL-High grade
54 579/08 1 2/12 F Mediastinal node
Neuroblastoma deposit 
lymphnode
55 582/08 8/12 F Pelvic mass Alveolar RMS
56 591/08 9 F L axillary node
Neuroblastoma deposit 
lymphnode
57 631/08 7 F Generalized LN
T cell lymphoblastic 
lymphoma/Leukemia
58 663/08 8 M Small intestinal mass
Marginal zone B cell 
lymphoma
59 786/08 5 M Generalized LN NHL-Lymphoblastic 
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S.
No.
HPE
No. Age Sex Site HPE Diagnosis
lymphoma
60 808/08 3 1/2 M L side of face PNET
61 815/08 5 M R mandible mass NHL
62 921/08 3 F Nephrectomy
Neuroblastoma- 
Differentiating
63 942/08 8 M Generalized LN NHL
64 960/08 7 M R femur Ewings/PNET
65 975/08 4 1/2 M Generalized LN NHL- High grade
66 1024/08 3 M Nephrectomy
Wilm`s tumor- blastemal 
predominance
67 1074/08 1 1/2 F
Posterior mediastinal 
mass
Neuroblastoma 
differentiating type
68 1137/08 3 F Abdominal mass
Neuroblastoma 
differentiating type
69 1257/08 3 M Generalized LN NHL High grade
70 1381/08 4 F Retropancreatic mass
Neuroblastoma poorly 
differentiated
71 1431/08 5 M Generalized LN NHL High grade
72 1432/08 4 M Nasal cavity mass PNET
82
ANNEXURE - 1
IHC RESULTS
NHL High Grade
SNo HPE No IHC Markers Results Diagnosis
1 15/07 LCA
CD20
CD3
Positive
Positive
Negative
Non Hodgkins 
Lymphoma B lineage
2 806/07 LCA
CD5
CD20
LMP
ACK
EMA
CD3
CD30
Focal Positive
Negative
Positive/Negative
Negative
Positve
Positive
Negative
Positive
Anaplastic Large Cell  
Lymphoma
3 1393/07 CD3
CD20
CD79a
CD43
TdT
CD99
Ki67
CD30
Positive
Negative
Negative
Positive
Negative
Positive
50 to 60%
Negative
Peripheral T cell  
Lymphoma
4 16/08 CD45
CD20
CD3
Positive
Positive
Negative
Non Hodgkins 
Lymphoma B lineage
5 458/08 CD45
CD20
CD3
Positive
Positive
Negative
Non Hodgkins 
Lymphoma B lineage
6 631/08 CD3
CD43
CD20
Ki67
TdT
CD99
Positive
Positive
Negative
40 to 60%
Negative
Positive
Peripheral T cell  
Lymphoma
7 815/08 LCA
Vimentin
Synaptophysin
CD56
Desmin
CD99
Ki67
CD20
CD79a
TdT
Positive
Positive
Negative
Negative
Negative
Negative
About 56%
Positive
Negative
Negative
Non  Hodgkins 
Lymphoma High Grade 
B Lineage
8 885/08 CD45
CD20
CD3
Positive
Positive
Negative
Non Hodgkins 
Lymphom
a B 
lineage
9 1427/08 CD45
CD20
CD3
Positive
Positive
Negative
Non Hodgkins 
Lymphoma B lineage
10 663/08 CD45
CD20
CD3
Positive
Positive
Negative
Non Hodgkins 
Lymphoma B lineage
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Ewings Sarcoma
SNo HPE No IHC Markers Scoring Diagnosis
1 480/08 CD99
CD45
Cytokeratin
Vimentin
Positive
Negative
Negative
Positive
Ewings/PNET
2 21/07 CD99
CD45
Cytokeratin
Vimentin
Positive
Negative
Negative
Positive
Ewings/PNET
3 619/07 CD99
Vimentin
MSA
Desmin
Synaptophysin
Positive
Positive
Negative
Positive/Desmin
Positive/Negative
Ewings/PNET
4 380/08 CD99
CD45
CD20
CD3
Cytokeratin
Positive
Negative
Negative
Negative
Negative
Ewings/PNET
5 960/08 CD99
LCA
Vimentin
Cytokeratin
Desmin
Synaptophysin
CD58
Positive
Positive
Negative
Positive
Negative
Negative
Negative
Ewings/PNET
Neuroblastoma
Sno HPE No IHC Markers Results Diagnosis
1 921/08 Chromogranin
Synaptophysin
S100
Positive
Focal 
Positive
Positive
Neuroblastoma
2 1381/08 Chromogranin
Synaptophysin
S100
Positive
Positive
Positive
Neuroblastom
a
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